SEARCH

SEARCH BY CITATION

References

  • Advani, R., Warnke, R., Sikic, B.I. & Horning, S. (1997) Treatment of angioimmunoblastic T-cell lymphoma with cyclosporine. Annals of Oncology, 8, 601603.
  • D’Amore, C.F., Radford, J., Jerkeman, M., Relander, T., Tilly, H., Osterborg, A., Morschhauser, F., Gramatzki, M., Dreyling, M., Bang, B., Baadsgaard, O. & Hagberg, H. (2007) Zanolimumab (HuMax-CD4™), a Monoclonal, Fully Human Antibody: Efficacy & Safety in Patients with Relapsed or Treatment-Refractory Non-Cutaneous, CD4+ Lymphoma, T-Cell. Blood (Annual Meeting, ASH Abstracts), 110, 3409.
  • Anagnostopoulos, I., Hummel, M., Finn, T., Tiemann, M., Korbjuhn, P., Dimmler, C., Gatter, K., Dallenbach, F., Parwaresch, M. & Stein, H. (1992) Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood, 80, 18041812.
  • Arkenau, H.T., Chong, G., Cunningham, D., Watkins, D., Sirohi, B., Chau, I., Wotherspoon, A., Norman, A., Horwich, A. & Matutes, E. (2007) Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experience. Haematologica, 92, 271272.
  • Armitage, J., Vose, J. & Weisenburger, D. (2008) International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. Journal of Clinical Oncology, 26, 41244130.
  • Ascani, S., Zinzani, P.L., Gherlinzoni, F., Sabattini, E., Briskomatis, A., De Vivo, A., Piccioli, M., Fraternali Orcioni, G., Pieri, F., Goldoni, A., Piccaluga, P.P., Zallocco, D., Burnelli, R., Leoncini, L., Falini, B., Tura, S. & Pileri, S.A. (1997) Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. Classification. Annals of Oncology, 8, 583592.
  • Attygalle, A., Al-Jehani, R., Diss, T.C., Munson, P., Liu, H., Du, M.Q., Isaacson, P.G. & Dogan, A. (2002) Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood, 99, 627633.
  • Attygalle, A.D., Diss, T.C., Munson, P., Isaacson, P.G., Du, M.Q. & Dogan, A. (2004) CD10 expression in extranodal dissemination of angioimmunoblastic T-cell lymphoma. American Journal of Surgical Pathology, 28, 5461.
  • Attygalle, A.D., Chuang, S.S., Diss, T.C., Du, M.Q., Isaacson, P.G. & Dogan, A. (2007a) Distinguishing angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified, using morphology, immunophenotype and molecular genetics. Histopathology, 50, 498508.
  • Attygalle, A.D., Kyriakou, C., Dupuis, J., Grogg, K.L., Diss, T.C., Wotherspoon, A.C., Chuang, S.S., Cabecadas, J., Isaacson, P.G., Du, M.Q., Gaulard, P. & Dogan, A. (2007b) Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression. American Journal of Surgical Pathology, 31, 10771088.
  • Bacon, C.M., Paterson, J.C., Liu, H., Payne, K., Munson, P., Du, M.Q. & Marafioti, T. (2008) Peripheral T-cell lymphoma with a follicular growth pattern: derivation from follicular helper T cells and relationship to angioimmunoblastic T-cell lymphoma. British Journal of Haematology, 143, 439441.
  • Baseggio, L., Berger, F., Morel, D., Delfau-Larue, M.H., Goedert, G., Salles, G., Magaud, J.P. & Felman, P. (2006) Identification of circulating CD10 positive T cells in angioimmunoblastic T-cell lymphoma. Leukemia, 20, 296303.
  • Bourgeois, E., Auxenfants, E., Jouffrey, C., Dubest, C., Mahieu, M. & Rose, C. (2000) [Efficacy of fludarabine in the treatment of angioimmunoblastic lymphoma (AIL)]. Annales de Medecine Interne (Paris), 151, 230231.
  • Bradley, S.L., Dines, D.E., Banks, P.M. & Hill, R.W. (1981) The lung in immunoblastic lymphadenopathy. Chest, 80, 312318.
  • Brauninger, A., Spieker, T., Willenbrock, K., Gaulard, P., Wacker, H.H., Rajewsky, K., Hansmann, M.L. & Kuppers, R. (2001) Survival and clonal expansion of mutating “forbidden” (immunoglobulin receptor-deficient) Epstein-Barr virus-infected B cells in angioimmunoblastic T-cell lymphoma. Journal of Experimental Medicine, 194, 927940.
  • Brown, H.A., Macon, W.R., Kurtin, P.J. & Gibson, L.E. (2001) Cutaneous involvement by angioimmunoblastic T-cell lymphoma with remarkable heterogeneous Epstein-Barr virus expression. Journal of Cutaneous Pathology, 28, 432438.
  • Bruggemann, M., White, H., Gaulard, P., Garcia-Sanz, R., Gameiro, P., Oeschger, S., Jasani, B., Ott, M., Delsol, G., Orfao, A., Tiemann, M., Herbst, H., Langerak, A.W., Spaargaren, M., Moreau, E., Groenen, P.J., Sambade, C., Foroni, L., Carter, G.I., Hummel, M., Bastard, C., Davi, F., Delfau-Larue, M.H., Kneba, M., Van Dongen, J.J., Beldjord, K. & Molina, T.J. (2007) Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936. Leukemia, 21, 215221.
  • Cho, Y.U., Chi, H.S., Park, C.J., Jang, S., Seo, E.J. & Huh, J. (2009) Distinct features of angioimmunoblastic T-cell lymphoma with bone marrow involvement. American Journal of Clinical Pathology, 131, 640646.
  • Cook, J.R., Craig, F.E. & Swerdlow, S.H. (2003) Benign CD10-positive T cells in reactive lymphoid proliferations and B-cell lymphomas. Modern Pathology, 16, 879885.
  • Corradini, P., Dodero, A., Zallio, F., Caracciolo, D., Casini, M., Bregni, M., Narni, F., Patriarca, F., Boccadoro, M., Benedetti, F., Rambaldi, A., Gianni, A.M. & Tarella, C. (2004) Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin’s lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells. Journal of Clinical Oncology, 22, 21722176.
  • Delmer, A., Mounier, N., Gaulard, P., Bouabdallah, R., Hermine, O., Salles, G., Emile, JF., Casasnovas, O., Tilly, H., Gisselbrecht, C. & Groupe d’Etude des Lymphomes de l’Adulte. (2003) Intensified induction therapy with etoposide (VP16) and high-dose cytarabine (Ara-C) in patients aged less than 60 years with peripheral T cell/NK lymphoma: preliminary results of the phase II GELA study LNH98T7. Proceeding American Society of Clinical Oncolology, 22, Abstract 2375.
  • Delmer, A., Fitoussi, O., Gaulard, P., Laurent, G., Bordessoule, D., Morchhauser, F., Ferme, C., Tilly, H., Gisselbrecht, C. & Coiffier, B. (2009) A phase II study of bortezomib in combination with intensified CHOP-like regimen (ACVBP) in patients with previously untreated T-cell lymphoma: results of the GELA LNH05–1T trial. Journal of Clinical Oncolology (ASCO Meeting Abstracts), 27 (Suppl. 15), 8554.
  • Dogan, A., Attygalle, A.D. & Kyriakou, C. (2003) Angioimmunoblastic T-cell lymphoma. British Journal of Haematology, 121, 681691.
  • Dogan, A., Ngu, L.S., Ng, S.H. & Cervi, P.L. (2005) Pathology and clinical features of angioimmunoblastic T-cell lymphoma after successful treatment with thalidomide. Leukemia, 19, 873875.
  • Dorfman, D.M., Brown, J.A., Shahsafaei, A. & Freeman, G.J. (2006) Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma. American Journal of Surgical Pathology, 30, 802810.
  • Dupuis, J., Boye, K., Martin, N., Copie-Bergman, C., Plonquet, A., Fabiani, B., Baglin, A.C., Haioun, C., Delfau-Larue, M.H. & Gaulard, P. (2006) Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells. American Journal of Surgical Pathology, 30, 490494.
  • Escalon, M.P., Liu, N.S., Yang, Y., Hess, M., Walker, P.L., Smith, T.L. & Dang, N.H. (2005) Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience. Cancer, 103, 20912098.
  • Fazilleau, N., Mark, L., McHeyzer-Williams, L.J. & McHeyzer-Williams, M.G. (2009) Follicular helper T cells: lineage and location. Immunity, 30, 324335.
  • Feller, A., Griesser, H., Schilling, C., Wacker, H., Dallenbach, F., Bartels, H., Kuse, R., Mak, T. & Lennert, K. (1988) Clonal gene rearrangement patterns correlate with immunophenotype and clinical parameters in patients with angioimmunoblastic lymphadenopathy. American Journal of Pathology, 133, 549556.
  • Feremans, W.W. & Khodadadi, E. (1987) Alpha-interferon therapy in refractory angioimmunoblastic lymphadenopathy. European Journal of Haematology, 39, 91.
  • Foss, H.D., Anagnostopoulos, I., Herbst, H., Grebe, M., Ziemann, K., Hummel, M. & Stein, H. (1995) Patterns of cytokine gene expression in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood, 85, 28622869.
  • Foss, F., Shak-Shie, N., Goy, A., Jacobson, E., Avandii, R., Komrokji, M., Pendergrass, K., Bolejack, V., Watts, K. & Acosta, M. (2008) Phase II study of Denileukin Diftitox with CHOP in PTCL. Annals of Oncology, 19(Suppl. 4), Abstract 096.
  • Frizzera, G., Moran, E. & Rappaport, H. (1974) Angio-immunoblastic lymphadenopathy with dysproteinemia. Lancet, i, 10701073.
  • Frizzera, G., Moran, E.M. & Rappaport, H. (1975) Angio-immunoblastic lymphadenopathy. Diagnosis and clinical course. American Journal of Medicine, 59, 803818.
  • Gallamini, A., Zaja, F., Patti, C., Billio, A., Specchia, M.R., Tucci, A., Levis, A., Manna, A., Secondo, V., Rigacci, L., Pinto, A., Iannitto, E., Zoli, V., Torchio, P., Pileri, S. & Tarella, C. (2007) Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial. Blood, 110, 23162323.
  • Gerlando, Q., Barbera, V., Ammatuna, E., Franco, V., Florena, A.M. & Mariani, G. (2000) Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma by combined methotrexate and prednisone. Haematologica, 85, 880881.
  • Gesk, S., Martin-Subero, J.I., Harder, L., Luhmann, B., Schlegelberger, B., Calasanz, M.J., Grote, W. & Siebert, R. (2003) Molecular cytogenetic detection of chromosomal breakpoints in T-cell receptor gene loci. Leukemia, 17, 738745.
  • Grogg, K.L., Attygalle, A.D., Macon, W.R., Remstein, E.D., Kurtin, P.J. & Dogan, A. (2005) Angioimmunoblastic T-cell lymphoma: a neoplasm of germinal-center T-helper cells? Blood, 106, 15011502.
  • Grogg, K.L., Attygale, A.D., Macon, W.R., Remstein, E.D., Kurtin, P.J. & Dogan, A. (2006) Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified. Modern Pathology, 19, 11011107.
  • Grogg, K.L., Morice, W.G. & Macon, W.R. (2007) Spectrum of bone marrow findings in patients with angioimmunoblastic T-cell lymphoma. British Journal of Haematology, 137, 416422.
  • Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K., Cleary, M.L., Delsol, G., De Wolf-Peeters, C., Falini, B. & Gatter, K.C. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84, 13611392.
  • Huang, Y., Moreau, A., Dupuis, J., Streubel, B., Petit, B., Le Gouill, S., Martin-Garcia, N., Copie-Bergman, C., Gaillard, F., Qubaja, M., Fabiani, B., Roncador, G., Haioun, C., Delfau-Larue, M.H., Marafioti, T., Chott, A. & Gaulard, P. (2009) Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas. American Journal of Surgical Pathology, 33, 682690.
  • Ikonomou, I.M., Tierens, A., Troen, G., Aamot, H.V., Heim, S., Lauritzsen, G.F., Valerhaugen, H. & Delabie, J. (2006) Peripheral T-cell lymphoma with involvement of the expanded mantle zone. Virchows Archiv, 449, 7887.
  • Jaffe, E., Harris, N., Stein, H. & Vardiman, J. (2001) Pathology and genetics. Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon.
  • Jayaraman, A.G., Cassarino, D., Advani, R., Kim, Y.H., Tsai, E. & Kohler, S. (2006) Cutaneous involvement by angioimmunoblastic T-cell lymphoma: a unique histologic presentation, mimicking an infectious etiology. Journal of Cutaneous Pathology, 33(Suppl. 2), 611.
  • Joly, B., Gaulard, P., Belhadj, K., Al Gnaoui, T., Dupuis, J., Divine, M., Rahmouni, A., Copie-Bergman, C., Delfau-Larue, M., Reyes, F. & Haioun, C. (2005) Rituximab in Combination with CHOP Regimen in Angioimmunoblastic T-Cell Lymphoma (AITL). Preliminary Results in 9 Patients Treated in a Single Institution. Blood, 106, 2686.
  • Kaneki, T., Kawashima, A., Akamatsu, T., Tanaka, N., Kubo, K., Koizumi, T., Sekiguchi, M., Hosaka, N., Honda, T., Koike, S. & Adachi, W. (1999) Immunoblastic lymphadenopathy-like T-cell lymphoma complicated by multiple gastrointestinal involvement. Journal of Gastroenterology, 34, 253259.
  • Kaneko, Y., Maseki, N., Sakurai, M., Takayama, S., Nanba, K., Kikuchi, M. & Frizzera, G. (1988) Characteristic karyotypic pattern in T-cell lymphoproliferative disorders with reactive “angioimmunoblastic lymphadenopathy with dysproteinemia-type” features. Blood, 72, 413421.
  • Kang, H.Y., Hwang, J.H., Park, Y.S., Bang, S.M., Lee, J.S., Chung, J.H. & Kim, H. (2007) Angioimmunoblastic T-cell lymphoma mimicking Crohn’s disease. Digestive Diseases and Sciences, 52, 27432747.
  • Karakas, T., Bergmann, L., Stutte, H.J., Jager, E., Knuth, A., Weidmann, E., Mitrou, P.S. & Hoelzer, D. (1996) Peripheral T-cell lymphomas respond well to vincristine, adriamycin, cyclophosphamide, prednisone and etoposide (VACPE) and have a similar outcome as high-grade B-cell lymphomas. Leukaemia & Lymphoma, 24, 121129.
  • Karube, K., Aoki, R., Nomura, Y., Yamamoto, K., Shimizu, K., Yoshida, S., Komatani, H., Sugita, Y. & Ohshima, K. (2008) Usefulness of flow cytometry for differential diagnosis of precursor and peripheral T-cell and NK-cell lymphomas: analysis of 490 cases. Pathology International, 58, 8997.
  • Kawano, R., Ohshima, K., Wakamatsu, S., Suzumiya, J., Kikuchi, M. & Tamura, K. (2005) Epstein-Barr virus genome level, T-cell clonality and the prognosis of angioimmunoblastic T-cell lymphoma. Haematologica, 90, 11921196.
  • Kerl, K., Vonlanthen, R., Nagy, M., Bolzonello, N.J., Gindre, P., Hurwitz, N., Gudat, F., Nador, R.G. & Borisch, B. (2001) Alterations on the 5′ noncoding region of the BCL-6 gene are not correlated with BCL-6 protein expression in T cell non-Hodgkin lymphomas. Laboratory Investigation, 81, 16931702.
  • Kim, J.G., Sohn, S.K., Chae, Y.S., Kim, D.H., Baek, J.H., Lee, K.B., Lee, J.J., Chung, I.J., Kim, H.J., Yang, D.H., Lee, W.S., Joo, Y.D. & Sohn, C.H. (2006) CHOP plus etoposide and gemcitabine (CHOP-EG) as front-line chemotherapy for patients with peripheral T cell lymphomas. Cancer Chemotherapy and Pharmacology, 58, 3539.
  • Konstantinou, K., Yamamoto, K., Ishibashi, F., Mizoguchi, Y., Kurata, M., Nakagawa, Y., Suzuki, K., Sawabe, M., Ohta, M., Miyakoshi, S., Crawley, J.T. & Kitagawa, M. (2009) Angiogenic mediators of the angiopoietin system are highly expressed by CD10-positive lymphoma cells in angioimmunoblastic T-cell lymphoma. British Journal of Haematology, 144, 696704.
  • Krenacs, L., Schaerli, P., Kis, G. & Bagdi, E. (2006) Phenotype of neoplastic cells in angioimmunoblastic T-cell lymphoma is consistent with activated follicular B helper T cells. Blood, 108, 11101111.
  • Kyriakou, C., Canals, C., Goldstone, A., Caballero, D., Metzner, B., Kobbe, G., Kolb, H.J., Kienast, J., Reimer, P., Finke, J., Oberg, G., Hunter, A., Theorin, N., Sureda, A. & Schmitz, N. (2008) High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. Journal of Clinical Oncology, 26, 218224.
  • Kyriakou, C., Canals, C., Finke, J., Kobbe, G., Harousseau, J.L., Kolb, H.J., Novitzky, N., Goldstone, A.H., Sureda, A. & Schmitz, N. (2009) Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantation. Journal of Clinical Oncology, 27, 39513958.
  • Lachenal, F. (2007) [Angioimmunoblastic T-cell lymphoma]. Presse Medicale, 36, 16551662.
  • Lachenal, F., Berger, F., Ghesquieres, H., Biron, P., Hot, A., Callet-Bauchu, E., Chassagne, C., Coiffier, B., Durieu, I., Rousset, H. & Salles, G. (2007) Angioimmunoblastic T-cell lymphoma: clinical and laboratory features at diagnosis in 77 patients. Medicine (Baltimore), 86, 282292.
  • Le Gouill, S., Milpied, N., Buzyn, A., De Latour, R.P., Vernant, J.P., Mohty, M., Moles, M.P., Bouabdallah, K., Bulabois, C.E., Dupuis, J., Rio, B., Gratecos, N., Yakoub-Agha, I., Attal, M., Tournilhac, O., Decaudin, D., Bourhis, J.H., Blaise, D., Volteau, C. & Michallet, M. (2008) Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire. Journal of Clinical Oncology, 26, 22642271.
  • Lee, S.S., Rudiger, T., Odenwald, T., Roth, S., Starostik, P. & Muller-Hermelink, H.K. (2003) Angioimmunoblastic T cell lymphoma is derived from mature T-helper cells with varying expression and loss of detectable CD4. International Journal of Cancer, 103, 1220.
  • Leich, E., Haralambieva, E., Zettl, A., Chott, A., Rudiger, T., Holler, S., Muller-Hermelink, H.K., Ott, G. & Rosenwald, A. (2007) Tissue microarray-based screening for chromosomal breakpoints affecting the T-cell receptor gene loci in mature T-cell lymphomas. Journal of Pathology, 213, 99105.
  • Lennert, K. (1979) [Nature, prognosis and nomenclature of angioimmunoblastic (lymphadenopathy (lymphogranulomatosis X or T-zone lymphoma)]. Deutsche Medizinische Wochenschrift, 104, 12461247.
  • Leung, C.Y., Ho, F.C., Srivastava, G., Loke, S.L., Liu, Y.T. & Chan, A.C. (1993) Usefulness of follicular dendritic cell pattern in classification of peripheral T-cell lymphomas. Histopathology, 23, 433437.
  • De Leval, L., Savilo, E., Longtine, J., Ferry, J.A. & Harris, N.L. (2001) Peripheral T-cell lymphoma with follicular involvement and a CD4+/bcl-6+ phenotype. American Journal of Surgical Pathology, 25, 395400.
  • De Leval, L., Rickman, D.S., Thielen, C., Reynies, A., Huang, Y.L., Delsol, G., Lamant, L., Leroy, K., Briere, J., Molina, T., Berger, F., Gisselbrecht, C., Xerri, L. & Gaulard, P. (2007) The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood, 109, 49524963.
  • De Leval, L., Bisig, B., Thielen, C., Boniver, J. & Gaulard, P. (2009) Molecular classification of T-cell lymphomas. Critical Reviews in Oncology/Hematology, 72, 125143.
  • Lome-Maldonado, C., Canioni, D., Hermine, O., Delabesse, E., Damotte, D., Raffoux, E., Gaulard, P., Macintyre, E. & Brousse, N. (2002) Angio-immunoblastic T cell lymphoma (AILD-TL) rich in large B cells and associated with Epstein-Barr virus infection. A different subtype of AILD-TL?. Leukemia, 16, 21342141.
  • Lukes, R.J. & Tindle, B.H. (1975) Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin’s disease. New England Journal of Medicine, 292, 18.
  • Macon, W.R., Williams, M.E., Greer, J.P. & Cousar, J.B. (1995) Paracortical nodular T-cell lymphoma. Identification of an unusual variant of peripheral T-cell lymphoma. American Journal of Surgical Pathology, 19, 297303.
  • Marinova, E., Han, S. & Zheng, B. (2007) Germinal center helper T cells are dual functional regulatory cells with suppressive activity to conventional CD4+ T cells. Journal of Immunology, 178, 50105017.
  • Martel, P., Laroche, L., Courville, P., Larroche, C., Wechsler, J., Lenormand, B., Delfau, M.H., Bodemer, C., Bagot, M. & Joly, P. (2000) Cutaneous involvement in patients with angioimmunoblastic lymphadenopathy with dysproteinemia: a clinical, immunohistological, and molecular analysis. Archives of Dermatology, 136, 881886.
  • Merchant, S.H., Amin, M.B. & Viswanatha, D.S. (2006) Morphologic and immunophenotypic analysis of angioimmunoblastic T-cell lymphoma: Emphasis on phenotypic aberrancies for early diagnosis. American Journal of Clinical Pathology, 126, 2938.
  • Mounier, N., Gisselbrecht, C., Briere, J., Haioun, C., Feugier, P., Offner, F., Recher, C., Stamatoullas, A., Morschhauser, F., Macro, M., Thieblemont, C., Sonet, A., Fabiani, B. & Reyes, F. (2004) All aggressive lymphoma subtypes do not share similar outcome after front-line autotransplantation: a matched-control analysis by the Groupe d’Etude des Lymphomes de l’Adulte (GELA). Annals of Oncology, 15, 17901797.
  • Mourad, N., Mounier, N., Briere, J., Raffoux, E., Delmer, A., Feller, A., Meijer, C.J., Emile, J.F., Bouabdallah, R., Bosly, A., Diebold, J., Haioun, C., Coiffier, B., Gisselbrecht, C. & Gaulard, P. (2008) Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d’Etude des Lymphomes de l’Adulte (GELA) trials. Blood, 111, 44634470.
  • Murakami, Y.I., Yatabe, Y., Sakaguchi, T., Sasaki, E., Yamashita, Y., Morito, N., Yoh, K., Fujioka, Y., Matsuno, F., Hata, H., Mitsuya, H., Imagawa, S., Suzuki, A., Esumi, H., Sakai, M., Takahashi, S. & Mori, N. (2007) c-Maf expression in angioimmunoblastic T-cell lymphoma. American Journal of Surgical Pathology, 31, 16951702.
  • Murayama, T., Imoto, S., Takahashi, T., Ito, M., Matozaki, S. & Nakagawa, T. (1992) Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with cyclosporin A. Cancer, 69, 25672570.
  • Nakamura, S. & Suchi, T. (1991) A clinicopathologic study of node-based, low-grade, peripheral T-cell lymphoma. Angioimmunoblastic lymphoma, T-zone lymphoma, and lymphoepithelioid lymphoma. Cancer, 67, 25662578.
  • Nakamura, S., Sasajima, Y., Koshikawa, T., Kitoh, K., Koike, K., Motoori, T., Ueda, R., Mori, S. & Suchi, T. (1995) Angioimmunoblastic T-cell lymphoma (angioimmunoblastic lymphadenopathy with dysproteinemia [AILD]-type T-cell lymphoma) followed by Hodgkin’s disease associated with Epstein-Barr virus. Pathology International, 45, 958964.
  • Nelson, M., Horsman, D.E., Weisenburger, D.D., Gascoyne, R.D., Dave, B.J., Loberiza, F.R., Ludkovski, O., Savage, K.J., Armitage, J.O. & Sanger, W.G. (2008) Cytogenetic abnormalities and clinical correlations in peripheral T-cell lymphoma. British Journal of Haematology, 141, 461469.
  • Nickelsen, M., Ziepert, M., Zeynalova, S., Glass, B., Metzner, B., Leithaeuser, M., Mueller-Hermelink, H.K., Pfreundschuh, M. & Schmitz, N. (2009) High-dose CHOP plus etoposide (MegaCHOEP) in T-cell lymphoma: a comparative analysis of patients treated within trials of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL). Annals of Oncology, DOI:10.1093/annonc/mdp211.
  • Niitsu, N., Okamoto, M., Nakamine, H., Aoki, S., Motomura, S. & Hirano, M. (2008) Clinico-pathologic features and outcome of Japanese patients with peripheral T-cell lymphomas. Hematological Oncology, 26, 152158.
  • O’Connor, O.A., Hamlin, P.A., Portlock, C., Moskowitz, C.H., Noy, A., Straus, D.J., Macgregor-Cortelli, B., Neylon, E., Sarasohn, D., Dumetrescu, O., Mould, D.R., Fleischer, M., Zelenetz, A.D., Sirotnak, F. & Horwitz, S. (2007) Pralatrexate, a novel class of antifol with high affinity for the reduced folate carrier-type 1, produces marked complete and durable remissions in a diversity of chemotherapy refractory cases of T-cell lymphoma. British Journal of Haematology, 139, 425428.
  • O’Connor, O.P.C., Pinter-Brown, L., Popplewell, L., Barlett, N., Shustov, C., Lechowicz, M.J., Savage, K.J., Coiffier, B., Jacobsen, E., Zinzani, P.J., Goy, A., Zain, J., Wilroy, S., Patterson, M., Boyd, A., Saunders, M.E., Cagnoni, P. & Horwitz, S.M. (2008) PROPEL: A Multi-Center Phase 2 Open-Label Study of Pralatrexate (PDX) with Vitamin B12 and Folic Acid Supplementation in Patients with Replapsed or Refractory Peripheral T-Cell Lymphoma. Blood (ASH Annual Meeting Abstracts), 112, 261.
  • Ortonne, N., Dupuis, J., Plonquet, A., Martin, N., Copie-Bergman, C., Bagot, M., Delfau-Larue, M.H., Gaulier, A., Haioun, C., Wechsler, J. & Gaulard, P. (2007) Characterization of CXCL13+ neoplastic t cells in cutaneous lesions of angioimmunoblastic T-cell lymphoma (AITL). American Journal of Surgical Pathology, 31, 10681076.
  • Oyama, T., Yamamoto, K., Asano, N., Oshiro, A., Suzuki, R., Kagami, Y., Morishima, Y., Takeuchi, K., Izumo, T., Mori, S., Ohshima, K., Suzumiya, J., Nakamura, N., Abe, M., Ichimura, K., Sato, Y., Yoshino, T., Naoe, T., Shimoyama, Y., Kamiya, Y., Kinoshita, T. & Nakamura, S. (2007) Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients. Clinical Cancer Research, 13, 51245132.
  • Patsouris, E., Noel, H. & Lennert, K. (1989) Angioimmunoblastic lymphadenopathy–type of T-cell lymphoma with a high content of epithelioid cells. Histopathology and comparison with lymphoepithelioid cell lymphoma. American Journal of Surgical Pathology, 13, 262275.
  • Pautier, P., Devidas, A., Delmer, A., Dombret, H., Sutton, L., Zini, J.M., Nedelec, G., Molina, T., Marolleau, J.P. & Brice, P. (1999) Angioimmunoblastic-like T-cell non Hodgkin’s lymphoma: outcome after chemotherapy in 33 patients and review of the literature. Leukaemia & Lymphoma, 32, 545552.
  • Piccaluga, P.P., Agostinelli, C., Califano, A., Carbone, A., Fantoni, L., Ferrari, S., Gazzola, A., Gloghini, A., Righi, S., Rossi, M., Tagliafico, E., Zinzani, P.L., Zupo, S., Baccarani, M. & Pileri, S.A. (2007) Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation. Cancer Research, 67, 1070310710.
  • Piekarz, R.L., Frye, R., Turner, M., Wright, J.J., Allen, S.L., Kirschbaum, M.H., Zain, J., Prince, H.M., Leonard, J.P., Geskin, L.J., Reeder, C., Joske, D., Figg, W.D., Gardner, E.R., Steinberg, S.M., Jaffe, E.S., Stetler-Stevenson, M., Lade, S., Fojo, A.T. & Bates, S.E. (2009) Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma. Journal of Clinical Oncology, 27, 54105417.
  • Pizzolo, G., Vinante, F., Agostini, C., Zambello, R., Trentin, L., Masciarelli, M., Chilosi, M., Benedetti, F., Dazzi, F. & Todeschini, G. (1987) Immunologic abnormalities in angioimmunoblastic lymphadenopathy. Cancer, 60, 24122418.
  • Pujol, R.M., Gallardo, F., Servitje, O., Marti, R.M., Bordes, R., Garcia-Muret, M.P., Estrach, M.T. & Nomdedeu, J.F. (2005) Peripheral T-cell lymphoma with secondary epithelioid granulomatous cutaneous involvement: a clinicopathologic study of four cases. Journal of Dermatology, 32, 541548.
  • Qubaja, M., Audouin, J., Moulin, J.C., Molina, T.J., Le Tourneau, A., Gaulard, P., Straub, P., Audhuy, B. & Diebold, J. (2009) Nodal follicular helper T-cell lymphoma may present with different patterns. A case report.. Human Pathology, 40, 264269.
  • Quintini, G., Iannitto, E., Barbera, V., Turri, D., Franco, V., Florena, A.M. & Mariani, G. (2001) Response to low-dose oral methotrexate and prednisone in two patients with angio-immunoblastic lymphadenopathy-type T-cell lymphoma. The Hematology Journal, 2, 393395.
  • Ree, H.J., Kadin, M.E., Kikuchi, M., Ko, Y.H., Go, J.H., Suzumiya, J. & Kim, D.S. (1998) Angioimmunoblastic lymphoma (AILD-type T-cell lymphoma) with hyperplastic germinal centers. American Journal of Surgical Pathology, 22, 643655.
  • Ree, H.J., Kadin, M.E., Kikuchi, M., Ko, Y.H., Suzumiya, J. & Go, J.H. (1999) Bcl-6 expression in reactive follicular hyperplasia, follicular lymphoma, and angioimmunoblastic T-cell lymphoma with hyperplastic germinal centers: heterogeneity of intrafollicular T-cells and their altered distribution in the pathogenesis of angioimmunoblastic T-cell lymphoma. Human Pathology, 30, 403411.
  • Reimer, P., Rudiger, T., Geissinger, E., Weissinger, F., Nerl, C., Schmitz, N., Engert, A., Einsele, H., Muller-Hermelink, H.K. & Wilhelm, M. (2009) Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study. Journal of Clinical Oncology, 27, 106113.
  • Rodriguez Pinilla, S.M., Roncador, G., Rodriguez-Peralto, J.L., Mollejo, M., Garcia, J.F., Montes-Moreno, S., Camacho, F.I., Ortiz, P., Limeres-Gonzalez, M.A., Torres, A., Campo, E., Navarro-Conde, P. & Piris, M.A. (2009) Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers. American Journal of Surgical Pathology, 33, 8190.
  • Rodriguez, J., Munsell, M., Yazji, S., Hagemeister, F.B., Younes, A., Andersson, B., Giralt, S., Gajewski, J., De Lima, M., Couriel, D., Romaguera, J., Cabanillas, F.F., Champlin, R.E. & Khouri, I.F. (2001) Impact of high-dose chemotherapy on peripheral T-cell lymphomas. Journal of Clinical Oncology, 19, 37663770.
  • Rodriguez-Justo, M., Attygalle, A.D., Munson, P., Roncador, G., Marafioti, T. & Piris, M.A. (2009) Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres: a neoplasia with origin in the outer zone of the germinal centre? Clinicopathological and immunohistochemical study of 10 cases with follicular T-cell markers. Modern Pathology, 22, 753761.
  • Rodriguez-Pinilla, S.M., Atienza, L., Murillo, C., Perez-Rodriguez, A., Montes-Moreno, S., Roncador, G., Perez-Seoane, C., Dominguez, P., Camacho, F.I. & Piris, M.A. (2009) Peripheral T-cell Lymphoma With Follicular T-cell Markers. American Journal of Surgical Pathology, 33, 8190.
  • Roncador, G., Garcia Verdes-Montenegro, J.F., Tedoldi, S., Paterson, J.C., Klapper, W., Ballabio, E., Maestre, L., Pileri, S., Hansmann, M.L., Piris, M.A., Mason, D.Y. & Marafioti, T. (2007) Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma. Haematologica, 92, 10591066.
  • Rudiger, T., Ichinohasama, R., Ott, M.M., Muller-Deubert, S., Miura, I., Ott, G. & Muller-Hermelink, H.K. (2000) Peripheral T-cell lymphoma with distinct perifollicular growth pattern: a distinct subtype of T-cell lymphoma? American Journal of Surgical Pathology, 24, 117122.
  • Rudiger, T., Weisenburger, D.D., Anderson, J.R., Armitage, J.O., Diebold, J., MacLennan, K.A., Nathwani, B.N., Ullrich, F. & Muller-Hermelink, H.K. (2002) Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin’s Lymphoma Classification Project. Annals of Oncology, 13, 140149.
  • Sakai, H., Tanaka, H., Katsurada, T., Yoshida, Y., Okamoto, E. & Ohno, H. (2007) Angioimmunoblastic T-cell lymphoma initially presenting with replacement of bone marrow and peripheral plasmacytosis. Internal Medicine, 46, 419424.
  • Sallah, A.S. & Bernard, S. (1996) Treatment of angioimmunoblastic lymphadenopathy with dysproteinemia using 2-chlorodeoxyadenosine. Annals of Hematology, 73, 295296.
  • Scarabello, A., Leinweber, B., Ardigo, M., Rutten, A., Feller, A.C., Kerl, H. & Cerroni, L. (2002) Cutaneous lymphomas with prominent granulomatous reaction: a potential pitfall in the histopathologic diagnosis of cutaneous T- and B-cell lymphomas. American Journal of Surgical Pathology, 26, 12591268.
  • Schlegelberger, B., Feller, A., Godde, W. & Lennert, K. (1990) Stepwise development of chromosomal abnormalities in angioimmunoblastic lymphadenopathy. Cancer Genetics and Cytogenetics, 50, 1529.
  • Schlegelberger, B., Zwingers, T., Hohenadel, K., Henne-Bruns, D., Schmitz, N., Haferlach, T., Tirier, C., Bartels, H., Sonnen, R. & Kuse, R. (1996) Significance of cytogenetic findings for the clinical outcome in patients with T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Journal of Clinical Oncology, 14, 593599.
  • Schmitz, N., Prange, E., Haferlach, T., Griesser, H., Sonnen, R., Schlegelberger, B., Claus, S. & Loffler, H. (1991) High-dose chemotherapy and autologous bone marrow transplantation in relapsing angioimmunoblastic lymphadenopathy with dysproteinemia (AILD). Bone Marrow Transplantation, 8, 503506.
  • Shah, Z.H., Harris, S., Smith, J.L. & Hodges, E. (2009) Monoclonality and oligoclonality of T cell receptor beta gene in angioimmunoblastic T cell lymphoma. Journal of Clinical Pathology, 62, 177181.
  • Shimoyama, M. & Minato, K. (1979) [Clinical, cytological and immunological analysis of T-cell type lymphoid malignancies: a classification of T-cell type lymphoid malignancy (author’s transl)]. [Rinsho Ketsueki] The Japanese Journal of Clinical Hematology, 20, 10561069.
  • Siegert, W., Nerl, C., Meuthen, I., Zahn, T., Brack, N., Lennert, K. & Huhn, D. (1991) Recombinant human interferon-alpha in the treatment of angioimmunoblastic lymphadenopathy: results in 12 patients. Leukemia, 5, 892895.
  • Siegert, W., Agthe, A., Griesser, H., Schwerdtfeger, R., Brittinger, G., Engelhard, M., Kuse, R., Tiemann, M., Lennert, K. & Huhn, D. (1992) Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group. Annals of Internal Medicine, 117, 364370.
  • Siegert, W., Nerl, C., Agthe, A., Engelhard, M., Brittinger, G., Tiemann, M., Lennert, K. & Huhn, D. (1995) Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma: prognostic impact of clinical observations and laboratory findings at presentation. The Kiel Lymphoma Study Group. Annals of Oncology, 6, 659664.
  • Smith, J.L., Hodges, E., Quin, C.T., McCarthy, K.P. & Wright, D.H. (2000) Frequent T and B cell oligoclones in histologically and immunophenotypically characterized angioimmunoblastic lymphadenopathy. American Journal of Pathology, 156, 661669.
  • Stacchini, A., Demurtas, A., Aliberti, S., Francia di Celle, P., Godio, L., Palestro, G. & Novero, D. (2007) The usefulness of flow cytometric CD10 detection in the differential diagnosis of peripheral T-cell lymphomas. American Journal of Clinical Pathology, 128, 854864.
  • Streubel, B., Vinatzer, U., Willheim, M., Raderer, M. & Chott, A. (2006) Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma. Leukemia, 20, 313318.
  • Strupp, C., Aivado, M., Germing, U., Gattermann, N. & Haas, R. (2002) Angioimmunoblastic lymphadenopathy (AILD) may respond to thalidomide treatment: two case reports. Leukaemia & Lymphoma, 43, 133137.
  • Suarez-Vilela, D. & Izquierdo-Garcia, F.M. (2003) Angioimmunoblastic lymphadenopathy-like T-cell lymphoma: cutaneous clinical onset with prominent granulomatous reaction. American Journal of Surgical Pathology, 27, 699700.
  • Swerdlow, S., Campo, E., Harris, N., Jaffe, E., Pileri, S., Stein, H., Thiele, J. & Vardiman, J. (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon.
  • Tan, B.T., Warnke, R.A. & Arber, D.A. (2006) The frequency of B- and T-cell gene rearrangements and epstein-barr virus in T-cell lymphomas: a comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without associated B-cell proliferations. The Journal of Molecular Diagnostics, 8, 466475.
  • Thorns, C., Bastian, B., Pinkel, D., Roydasgupta, R., Fridlyand, J., Merz, H., Krokowski, M., Bernd, H.W. & Feller, A.C. (2007) Chromosomal aberrations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma unspecified: A matrix-based CGH approach. Genes, Chromosomes and Cancer, 46, 3744.
  • Tilly, H., Lepage, E., Coiffier, B., Blanc, M., Herbrecht, R., Bosly, A., Attal, M., Fillet, G., Guettier, C., Molina, T.J., Gisselbrecht, C. & Reyes, F. (2003) Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma. Blood, 102, 42844289.
  • Tobinai, K., Minato, K., Ohtsu, T., Mukai, K., Kagami, Y., Miwa, M., Watanabe, S. & Shimoyama, M. (1988) Clinicopathologic, immunophenotypic, and immunogenotypic analyses of immunoblastic lymphadenopathy-like T-cell lymphoma. Blood, 72, 10001006.
  • Troxell, M.L., Schwartz, E.J., Van De Rijn, M., Ross, D.T., Warnke, R.A., Higgins, J.P. & Natkunam, Y. (2005) Follicular dendritic cell immunohistochemical markers in angioimmunoblastic T-cell lymphoma. Applied Immunohistochemistry & Molecular Morphology , 13, 297303.
  • Tsochatzis, E., Vassilopoulos, D., Deutsch, M., Filiotou, A., Tasidou, A. & Archimandritis, A.J. (2005) Angioimmunoblastic T-cell lymphoma-associated arthritis: case report and literature review. Journal of Clinical Rheumatology, 11, 326328.
  • Uherova, P., Ross, C.W., Finn, W.G., Singleton, T.P., Kansal, R. & Schnitzer, B. (2002) Peripheral T-cell lymphoma mimicking marginal zone B-cell lymphoma. Modern Pathology, 15, 420425.
  • Vinuesa, C.G., Tangye, S.G., Moser, B. & Mackay, C.R. (2005) Follicular B helper T cells in antibody responses and autoimmunity. Nature Reviews. Immunology, 5, 853865.
  • Vrsalovic, M.M., Korac, P., Dominis, M., Ostojic, S., Mannhalter, C. & Kusec, R. (2004) T- and B-cell clonality and frequency of human herpes viruses-6, -8 and Epstein Barr virus in angioimmunoblastic T-cell lymphoma. Hematological Oncology, 22, 169177.
  • Weiss, L., Strickler, J., Dorfman, R., Horning, S., Warnke, R. & Sklar, J. (1986) Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. American Journal of Pathology, 122, 392397.
  • Weiss, L.M., Jaffe, E.S., Liu, X.F., Chen, Y.Y., Shibata, D. & Medeiros, L.J. (1992) Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Blood, 79, 17891795.
  • Willenbrock, K., Roers, A., Seidl, C., Wacker, H.H., Kuppers, R. & Hansmann, M.L. (2001) Analysis of T-cell subpopulations in T-cell non-Hodgkin’s lymphoma of angioimmunoblastic lymphadenopathy with dysproteinemia type by single target gene amplification of T cell receptor- beta gene rearrangements. American Journal of Pathology, 158, 18511857.
  • Willenbrock, K., Renne, C., Gaulard, P. & Hansmann, M.L. (2005) In angioimmunoblastic T-cell lymphoma, neoplastic T cells may be a minor cell population. A molecular single-cell and immunohistochemical study. Virchows Archiv, 446, 1520.
  • Willenbrock, K., Brauninger, A. & Hansmann, M.L. (2007) Frequent occurrence of B-cell lymphomas in angioimmunoblastic T-cell lymphoma and proliferation of Epstein-Barr virus-infected cells in early cases. British Journal of Haematology, 138, 733739.
  • Xerri, L., Chetaille, B., Seriari, N., Attias, C., Guillaume, Y., Arnoulet, C. & Olive, D. (2008) Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia. Human Pathology, 39, 10501058.
  • Yu, H., Shahsafaei, A. & Dorfman, D.M. (2009) Germinal-center T-helper-cell markers PD-1 and CXCL13 are both expressed by neoplastic cells in angioimmunoblastic T-cell lymphoma. American Journal of Clinical Pathology, 131, 3341.
  • Yuan, C.M., Vergilio, J.A., Zhao, X.F., Smith, T.K., Harris, N.L. & Bagg, A. (2005) CD10 and BCL6 expression in the diagnosis of angioimmunoblastic T-cell lymphoma: utility of detecting CD10+ T cells by flow cytometry. Human Pathology, 36, 784791.
  • Zettl, A., Lee, S.S., Rudiger, T., Starostik, P., Marino, M., Kirchner, T., Ott, M., Muller-Hermelink, H.K. & Ott, G. (2002) Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angloimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified. American Journal of Clinical Pathology, 117, 368379.
  • Zhao, W.L., Mourah, S., Mounier, N., Leboeuf, C., Daneshpouy, M.E., Legres, L., Meignin, V., Oksenhendler, E., Maignin, C.L., Calvo, F., Briere, J., Gisselbrecht, C. & Janin, A. (2004) Vascular endothelial growth factor-A is expressed both on lymphoma cells and endothelial cells in angioimmunoblastic T-cell lymphoma and related to lymphoma progression. Laboratory Investigation, 84, 15121519.
  • Zhou, Y., Attygalle, A.D., Chuang, S.S., Diss, T., Ye, H., Liu, H., Hamoudi, R.A., Munson, P., Bacon, C.M., Dogan, A. & Du, M.Q. (2007) Angioimmunoblastic T-cell lymphoma: histological progression associates with EBV and HHV6B viral load. British Journal of Haematology, 138, 4453.
  • Zinzani, P.L., Magagnoli, M., Bendandi, M., Orcioni, G.F., Gherlinzoni, F., Albertini, P., Pileri, S.A. & Tura, S. (1998) Therapy with gemcitabine in pretreated peripheral T-cell lymphoma patients. Annals of Oncology, 9, 13511353.